Physician profile
David S Mora
NPI 1255305256
$2,489.04
in general payments reported to CMS, 2019-2025
16 companies · $747 in 2025
The $747 reported for 2025 was more than what 86% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $390 · 2020: $110 · 2021: $196 · 2022: $134 · 2023: $379 · 2024: $532 · 2025: $747.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,620 · Entertainment: $39.13.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,619.87 |
| Entertainment | $39.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $556.52 | 2022-2025 | Miebo, Xiidra, Vyzulta |
| Dompe US, INC. | $380.26 | 2023-2025 | Oxervate |
| Alcon Vision LLC | $322.44 | 2022-2025 | Rocklatan |
| Allergan, INC. | $312.20 | 2019-2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $271.63 | 2019-2021 | |
| Abbvie INC. | $235.71 | 2022-2025 | |
| Apellis Pharmaceuticals, INC. | $121.36 | 2025 | Syfovre |
| Oyster Point Pharma, INC. | $43.12 | 2022-2023 | Tyrvaya |
| Sun Pharmaceutical Industries INC. | $42.62 | 2019-2020 | |
| Kala Pharmaceuticals, INC. | $41.85 | 2021-2022 | |
| Shire North American Group INC | $40.73 | 2019 | |
| Optos, INC. | $39.13 | 2025 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Coopervision INC. | $32.15 | 2024 | Myday Contact Lens |
| Thea Pharma INC. | $17.39 | 2023 | |
| Eyevance Pharmaceuticals LLC | $16.64 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $15.29 | 2025 | Izervay |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Mora listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.